Guardant Health, Inc. (GH) vs Revvity Inc. (RVTY)
- Guardant Health, Inc. GH 154.16 −8.55%
- Revvity Inc. RVTY 150.97 −5.31%
Guardant Health, Inc. and Revvity Inc. are both Diagnostics & Research companies. Guardant Health, Inc. is the larger, with a market value of $20.6B against $16.8B — 1.2× the size. Guardant Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Revvity Inc. trades at 71.9×. Guardant Health, Inc. grew revenue faster over the last twelve months: 41.7% against 4.56%. Revvity Inc. has the higher net margin (8.61% vs −37.9%) and the higher return on invested capital (2.50% vs −25.7%). Across the 18 metrics below, Guardant Health, Inc. leads on 9 and Revvity Inc. on 9.
Valuation
Profitability
| Metric | GH | RVTY | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 65.19% | 55.91% | 48.32% |
| Operating margin | (39.41%) | 12.65% | (5.68%) |
| Net margin | (37.93%) | 8.61% | (4.10%) |
| Free cash flow margin | (18.15%) | 20.48% | 0.00% |
| Return on equity | 153.90% | 0.00% | 0.00% |
| Return on assets | (30.68%) | 2.14% | (6.05%) |
| Return on invested capital | (25.68%) | 2.50% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack